Epirubicin

== Information about Epirubicin ==  Epirubicin is an analogue of doxorubicin that has activity against many forms of cancer, but is used largely in the treatment of advanced breast cancer. 

FDA approval information for Epirubicin

Epirubicin was approved for use in the United States in 1999.  Current indications are limited to use in patients with breast cancer who have evidence of lymph node involvement after primary resection of the breast tumor. 

Dosage and administration for Epirubicin

Epirubicin is available as a solution generically and under the brand name Ellence in single use vials containing 50 or 200 mg [2 mg/mL].  The dose of epirubicin is typically 60 to 100 mg per meter squared given in combination with cyclophosphamide and fluorouracil.  It is administered by slow intravenous infusion on days 1 and 8 of 28 day cycles. 

Side effects of Epirubicin

Common side effects are similar to those of doxorubicin and include cardiac toxicity and secondary malignancies.

 

The article on Epirubicin is a stub. YOU can help Wikimd by expanding it!

Medication resources

WikiMD is a sponsored by W8MD Weight loss, sleep and medical aesthetics.

Learn more

• Dailymed label info
• Scientific articles

edit 

About WikiMD

About us: WikiMD is a free medical encyclopedia and wellnesspedia moderated by medical professionals.

Our mission: Provide up to date physician reviewed health, nutrition and wellness information for free in over 100 languages.

Join us: This article is a stub. Help improve Epirubicin or others. Do not trust amateurs with your life! Join us in this effort!. Paid editors welcome.